Signal Genetics Inc. (SGNL) announced Monday that it has scheduled a special meeting of its stockholders for the morning of February 10. Shareholders will vote on matters related to the proposed merger with Miragen Therapeutics Inc. and the sale of Signal's MyPRS intellectual property assets.
from RTT - Before the Bell http://ift.tt/2ij2076
via IFTTT
No comments:
Post a Comment